ArticleJournal of clinical and translational hepatology2019
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B.
Open access · diamondAbstract read
In one paragraph
Article in Journal of clinical and translational hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 17 citations in OpenAlex.
- Impact of Alanine Transaminase Thresholds on Treatment Eligibility of Patients with Chronic Hepatitis B: A Cross-sectional Study of the China Registry of Hepatitis B.Journal of clinical and translational hepatology · 2025Article
- [Distribution characteristics of serum HBsAg levels in Chinese patients with chronic hepatitis B based on CR-HepB].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025Article
- Latest insights into the epidemiology, characteristics, and therapeutic strategies of chronic hepatitis B patients in indeterminate phase.European journal of medical research · 2024Review
- [Comparison of the population covered by the 2024 version of the WHO's hepatitis B prevention and treatment guidelines and the Chinese antiviral treatment guidelines].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024Article
- Comprehensive approach to controlling chronic hepatitis B in China.Clinical and molecular hepatology · 2024Review
- Article
- Trends of Mortality in End-Stage Liver Disease - China, 2008-2020.China CDC weekly · 2023Article
- [Ten-year changes in clinical characteristics and antiviral treatment patterns of chronic hepatitis B in China: a CR-HepB-based real-world study].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023Article
- Article
- Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China.Journal of clinical and translational hepatology · 2022Article
- [Observation of PD-1Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022Article
- Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?Journal of gastroenterology and hepatology · 2022Article
- Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy.Frontiers in microbiology · 2022Article
- [Correlation among age, sex, and liver diseases-related mortality risk in patients with hepatitis B virus-related liver cirrhosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021Article
- [Analysis of clinical characteristics of 481 HBV-related liver cirrhotic patients with low viral load].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021Article
- Control of Chronic Hepatitis B in China: Perspective of Diagnosis and Treatment.China CDC weekly · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
54 authors at 20 institutions in 1 country.
Shan ShanLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center for Digestive Diseases, Beijing, China.
Hong YouLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center for Digestive Diseases, Beijing, China.
Junqi NiuDepartment of Hepatology, First Hospital of Jilin University, Changchun, Jilin, China.
Jia ShangDepartment of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Wen XieCenter of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yuexin ZhangDepartment of Infectious Diseases, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Xun LiDepartment of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Hong RenDepartment of Infectious Diseases, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hong TangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Huiguo DingDepartment of Gastroenterology and Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Xihong WangCenter of Infectious Diseases, The Third People's Hospital of Taiyuan, Taiyuan, Shanxi, China.
Yuemin NanDepartment of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Xiaoguang DouDepartment of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Tao HanDepartment of Hepatology, Tianjin Third Central Hospital, Tianjin Medical University, Tianjin, China.
Lingyi ZhangDepartment of Hepatology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Xiaoqing LiuDepartment of Infectious Diseases, Peking Union Medical College Hospital, Beijing, China.
Cunliang DengDepartment of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, Gansu, China.
Jilin ChengDepartment of Gastroenterology, Shanghai Public Health Clinical Center, Shanghai, China.
Xiaozhong WangDepartment of Hepatology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Urumqi, Xinjiang, China.
Qing XieDepartment of Infectious Diseases, Shanghai Ruijin Hospital, Jiao Tong University School of Medicine, Shanghai, China.
Shumei LinDepartment of Infectious Diseases, The First Affiliated Hospital of Xian Jiao Tong University, Xi'an, Shaanxi, China.
Yan HuangDepartment of Infectious Diseases, Xiangya Hospital Central South University, Changsha, Hunan, China.
Youqing XuDepartment of Digestive System, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yong XiongDepartment of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Wu LiDepartment of Infectious Diseases, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Xuebing YanDepartment of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Henan, China.
Hongxin PiaoDepartment of Infectious Diseases, Yanbian University Hospital, Yanji, Jilin, China.
Wenxiang HuangDepartment of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qinghua LuDepartment of Hepatology, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai, China.
Weijin GongDepartment of Infectious Diseases, Xinjiang Changji Prefecture People's Hospital, Changji, Xinjiang, China.
Shiping LiDepartment of Hepatopancreatobiliary Surgery, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China.
Xiaoxuan HuDepartment of Hepatology, Hunan Provincial People's Hospital, Changsha, Hunan, China.
Xiaolan ZhangDepartment of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Shourong LiuDepartment of Hepatology, Xixi Hospital of Hangzhou, Hangzhou, Zhejiang, China.
Yufang LiDepartment of Infectious Diseases, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Dongliang YangDepartment of Infectious Diseases, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
Hai LiDepartment of Hepatopancreatobiliary and Splenic Medicine, The Affiliated Hospital, Logistics University of People's Armed Police Force, Tianjin, China.
Caixia YangDepartment of Infectious Diseases, Infectious Disease Hospital of Wuhai, Wuhai, Inner Mongolia, China.
Mingliang ChengDepartment of Infectious Diseases, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Liaoyun ZhangDepartment of Infectious Diseases, The First Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Huanwei ZhengDepartment of Infectious Diseases, The Fifth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.
Xinhua LuoDepartment of Infectious Diseases, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Feng LinDepartment of Infectious Diseases, Hainan General Hospital, Haikou, Hainan, China.
Lei WangDepartment of Infectious Diseases, The Second Hospital of Shandong University, Jinan, Shandong, China.
Guanghua XuDepartment of Infectious Diseases, Yanan University Affiliated Hospital, Yan'an, Shaanxi, China.
Xiaoyuan XuDepartment of Infectious Diseases, Peking University First Hospital, Beijing, China.
Lai WeiPeking University Hepatology Institute, Peking University People's Hospital, Beijing, China.
Jinlin HouInstitute of Hepatology and Department of Infectious Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Zhongping DuanArtificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Hui ZhuangDepartment of Microbiology and Infectious Disease Center, Peking University Health Science Center, Beijing, China.
Xizhong YangThe China Foundation of Hepatitis Prevention and Control, Beijing China.
Yuanyuan KongCenter for Clinical Epidemiology and EBM, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing, China.
Jidong JiaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center for Digestive Diseases, Beijing, China.
CR-HepB study group, Beijing, China
Capital Medical University · CNLanzhou University · CNPeking University · CNBeijing Friendship Hospital · CNGuiyang Medical University · CNNational Clinical Research Center for Digestive Diseases · CNAffiliated Hospital of Southwest Medical University · CNBeijing Tian Tan Hospital · CNBeijing YouAn Hospital · CNCentral South University · CNChangji University · CNChina Foundation for Hepatitis Prevention and Control · CNChina Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNChongqing Medical University · CNFourth People's Hospital of Taiyuan · CNHenan Provincial People's Hospital · CNJilin University · CNKunming Medical University · CNNingxia Medical University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hepatitis BRegistryTreatment
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.